Xencor, Inc Income Tax Paid Foreign After Refund Received
Xencor, Inc (XNCR) reported Income Tax Paid Foreign After Refund Received of $180.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxPaidForeignAfterRefundReceived · last filed 2026-08-05
- Xencor, Inc income tax paid foreign after refund received for the quarter ending 2026-06-30 was $0.00.
- Xencor, Inc income tax paid foreign after refund received for the quarter ending 2026-03-31 was $180.00K.
- Xencor, Inc income tax paid foreign after refund received for the quarter ending 2025-06-30 was $0.00.
- Xencor, Inc income tax paid foreign after refund received for the quarter ending 2025-03-31 was $0.00.
| Period end | Income Tax Paid Foreign After Refund Received 3 month | Income Tax Paid Foreign After Refund Received 6 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $180.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $180.00K 10-Q · filed 2026-05-06 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |